Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Medications For Heart Failure Market?

The market for heart failure drugs has seen impressive growth in the past few years. Its size is expected to increase from $10.14 billion in 2024 to $10.79 billion in 2025, marking a compound annual growth rate (CAGR) of 6.4%. The historical growth is attributable to increased cases of heart diseases, heightened diagnosis and awareness, regulatory endorsements and backing, escalating expenditures on R&D for heart drugs, and the uptake of telemedicine and remote monitoring technologies.

The heart failure treatment market is projected to experience significant expansion in the upcoming years, with the anticipation of reaching a market size of $14.07 billion by 2029, exhibiting a compound annual growth rate of 6.8%. The factors attributing to the projected growth during the forecast period comprise an increase in individualized and precision therapies, the escalating global prevalence of lifestyle diseases, a robust pipeline of combination treatments and fixed-dose formulations, the rise in clinical evidence and updated guidelines, alongside elevated urbanization. Prominent trends during the forecast period are the growth of SGLT2 inhibitors, the integration of digital health, the use of remote monitoring devices and AI-based analytics, a heightened focus on HFpEF therapy, and continuous research and development.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24315&type=smp

What Growth-Enabling Forces Are Impacting The Medications For Heart Failure Market?

The escalating occurrence of cardiovascular diseases is anticipated to stimulate the progression of the market for heart failure medications. Cardiovascular diseases are conditions that affect the heart and blood vessels, often leading to serious complications such as heart attacks and strokes. The uptick of cardiovascular diseases is mainly due to inactive lifestyles that deteriorate the health of the heart and vessels over time. With an increasing rate of cardiovascular diseases, the need for effective therapies also escalates, inviting more expenditure in heart failure drugs. As the disease becomes more pervasive, drug companies are prioritizing the creation and enhancement of treatments to better control symptoms and improve patient results. For example, in September 2024, the Heart Failure Society of America (HFSA), a US-based group of heart failure specialists, reported that approximately 6.7 million Americans aged 20 and older currently contend with heart failure (HF), with an expectation for this figure to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Consequently, the mounting occurrence of cardiovascular diseases is fuelling the expansion of the market for heart failure medications.

How Does The Medications For Heart Failure Market Differ By Segment?

The medications for heart failuremarket covered in this report is segmented –

1) By Drug Class: Angiotensin-Converting Enzyme (ACE) Inhibitors; Beta Blockers; Diuretics; Aldosterone Antagonists; Angiotensin II Receptor Blockers (ARBs); Other Drug Classes

2) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

4) By Application: Hospital; Clinic; Other Applications

Subsegments:

1) By Angiotensin-Converting Enzyme (ACE) Inhibitors: Enalapril; Lisinopril; Ramipril; Captopril; Perindopril; Other Angiotensin-Converting Enzyme (ACE) Inhibitors

2) By Beta Blockers: Carvedilol; Metoprolol Succinate; Bisoprolol; Nebivolol; Other Beta Blockers

3) By Diuretics: Loop Diuretics; Thiazide Diuretics; Potassium-Sparing Diuretics; Other Diuretics

4) By Aldosterone Antagonists: Spironolactone; Eplerenone; Other Aldosterone Antagonists

5) By Angiotensin II Receptor Blockers (ARBs): Valsartan; Losartan; Candesartan; Irbesartan; Other Angiotensin II Receptor Blockers (ARBs)

6) By Other Drug Classes: Angiotensin Receptor-Neprilysin Inhibitors; Ivabradine; Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors; Hydralazine Or Isosorbide Dinitrate; Digoxin; Other Medications

What Are The Dominant Trends Currently Seen In The Medications For Heart Failure Market?

Leading businesses in the heart failure medication market are concentrating on the creation of sophisticated medicines such as sodium-glucose cotransporter (SGLT) inhibitors for improved and effective long-term handling of heart failure signs and complications. These SGLT inhibitors are modern drugs designed to address glucose reabsorption procedures to manage heart failure, boost efficiency, and maximize cardiovascular health. For example, in May 2023, US biopharmaceutical firm Lexicon Pharmaceuticals unveiled Inpefa (sotagliflozin), which gained approval from the Food and Drug Administration (FDA). This once-daily oral tablet is intended to mitigate the risk of cardiovascular death, heart failure hospitalizations, and urgent heart failure visits in adults suffering from heart failure or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risks. This endorsement signifies a substantial achievement for Lexicon, as Inpefa, the first dual SGLT1/SGLT2 inhibitor, debuts in the market, presenting a new treatment alternative for heart failure patients with a wide array of conditions.

Who Are The Most Influential Companies In The Medications For Heart Failure Market?

Major companies operating in the medications for heart failure market are Merck & Co. Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals Inc., Steris Pharma, CSPC Pharmaceutical, Hikma Pharmaceuticals PLC, Cadila Pharmaceuticals, Ionis Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Hainan Poly Pharm. Co. Ltd., Addii Biotech, Lunan Pharmaceutical Group, Mylan Laboratories Inc., Neuracle Lifesciences Private Limited, JM Laboratories, Lexicon Pharmaceuticals.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/medications-for-heart-failure-global-market-report

Which Region Is Leading Innovation In The Medications For Heart Failure Market?

North America was the largest region in the medications for the heart failure market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medications for heart failure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24315&type=smp

Browse Through More Reports Similar to the Global Medications For Heart Failure Market 2025, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Flea Tick And Heartworm Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flea-tick-and-heartworm-products-global-market-report

Implantable Heart Pacemaker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model